Biology Reference
In-Depth Information
78. Singhal H, Bautista DS, Tonkin KS, O
Malley FP, Tuck AB, Chambers AF, Harris JF. (1997)
Elevated plasma osteopontin in metastatic breast cancer associated with increased tumor
burden and decreased survival. Clin Cancer Res 3:605-11.
79. Takahashi F, Akutagawa S, Fukumoto H, Tsukiyama S, Ohe Y, Takahashi K, Fukuchi Y, Saijo
N, Nishio K. (2002) Osteopontin induces angiogenesis of murine neuroblastoma cells in mice.
Int J Cancer 98:707-12.
80. Tallquist MD, French WJ, Soriano P. (2003) Additive effects of PDGF receptor beta signaling
pathways in vascular smooth muscle cell development. PLoS Biol 1:288-99.
81. Tanimoto T, Jin ZG, Berk BC. (2002) Transactivation of vascular endothelial growth factor
(VEGF) receptor Flk-1/KDR is involved in sphingosine 1-phosphate-stimulated phosphoryla-
tion of Akt and endothelial nitric-oxide synthase (eNOS). J Biol Chem 277:42997-3001.
82. Tenaglia AN, Peters KG, Sketch MH, Jr, Annex BH. (1998) Neovascularization in atherec-
tomy specimens from patients with unstable angina: implications for pathogenesis of unstable
angina. Am Heart J 135:10-4.
83. Thuringer D, Maulon L, Frelin C. (2002) Rapid transactivation of the vascular endothelial
growth factor receptor KDR/Flk-1 by the bradykinin B2 receptor contributes to endothe-
lial nitric-oxide synthase activation in cardiac capillary endothelial cells. J Biol Chem 277:
2028-32.
84. Townsend KP, Obregon D, Quadros A, Patel N, Volmar C, Paris D, Mullan M. (2002)
Proinflammatory and vasoactive effects of Abeta in the cerebrovasculature. Ann N Y Acad
Sci 977:65-76.
85. Ventura MA, Thomopoulos P. (1995) ADP and ATP activate distinct signaling pathways
in human promonocytic U-937 cells differentiated with 1,25-dihydroxy-vitamin D3. Mol
Pharmacol 47:104-14.
86. Wang DJ, Huang NN, Heppel LA. (1992) Extracellular ATP and ADP stimulate proliferation
of porcine aortic smooth muscle cells. J Cell Physiol 153:221-33.
87. Wang M, Kong Q, Gonzalez FA, Sun G, Erb L, Seye C, Weisman GA. (2005) P2Y
2
nucleotide
receptor interaction with
α
v
integrin mediates astrocyte migration. J Neurochem 95:
630-40.
88. Weisman GA, Yu N, Liao Z, Gonzalez F, Erb L, Seye CI. (2006) P2 receptors in health and
disease. Biotechnol Genet Eng Rev 22:171-95.
89. Weller RO, Yow HY, Preston SD, Mazanti I, Nicoll JA. (2002) Cerebrovascular disease is a
major factor in the failure of elimination of Abeta from the aging human brain: implications
for therapy of Alzheimer's disease. Ann N Y Acad Sci 977:162-8.
90. Yang S, Buxton IL, Probert CB, Talbot JN, Bradley ME. (1996) Evidence for a discrete UTP
receptor in cardiac endothelial cells. Br J Pharmacol 117:1572-8.
91. Zeng H, Sanyal S, Mukhopadhyay D. (2001) Tyrosine residues 951 and 1059 of vas-
cular endothelial growth factor receptor-2 (KDR) are essential for vascular permeability
factor/vascular endothelial growth factor-induced endothelium migration and proliferation,
respectively. J Biol Chem 276:32714-9.
92. Zimmermann H, Braun N. (1996) Extracellular metabolism of nucleotides in the nervous
system. J Auton Pharmacol 16:397-400.
Search WWH ::
Custom Search